DAVID SARRAF
Allopathic & Osteopathic Physicians|Ophthalmology LOS ANGELES, CA NPI 1477577591
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology CA Amgen Inc. All categories
General Payments — all program years on this page
$133,041.53
- Category: General Payments
- Program years: PY2018–2024
- Record count: 49
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $23,259.97 across 12 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $17,153.41 | 5 |
| Food and Beverage | $6,082.13 | 6 |
| Travel and Lodging | $24.43 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $14,449.50 | 7 |
| Visionix USA, Inc | $6,000.00 | 2 |
| Genentech USA, Inc. | $2,750.00 | 1 |
| Apellis Pharmaceuticals, Inc. | $43.92 | 1 |
| ABBVIE INC. | $16.55 | 1 |
By program year
Records — PY2024 (12)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1106021700 | ABBVIE INC. | $16.55 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117675703 | Amgen Inc. | $16.42 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117675705 | Amgen Inc. | $5.24 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117675707 | Amgen Inc. | $1,054.27 | 06/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1117675709 | Amgen Inc. | $4,915.00 | 06/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1117675711 | Amgen Inc. | $7,379.87 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1117675713 | Amgen Inc. | $1,054.27 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1117675715 | Amgen Inc. | $24.43 | 10/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1132998928 | Genentech USA, Inc. | $2,750.00 | 04/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1154005333 | Visionix USA, Inc | $3,000.00 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154005335 | Visionix USA, Inc | $3,000.00 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154019778 | Apellis Pharmaceuticals, Inc. | $43.92 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.